Keyphrases
Denmark
100%
Early Intervention
100%
Close Monitoring
100%
Cystic Fibrosis
100%
Management Principles
100%
Intervention Management
100%
High Dose
20%
Europe
20%
Lung Disease
20%
High Prevalence
20%
Clinical Research
20%
Treatment Risk
20%
Antimicrobial Resistance
20%
Early Treatment
20%
Improved Outcomes
20%
Lung Function
20%
European Standards
20%
Standard of Care
20%
Associated Complications
20%
Cystic Fibrosis Foundation
20%
Treatment Burden
20%
Preemptive Treatment
20%
Lung-other
20%
Dose Combination
20%
Continuous Evaluation
20%
Approaches to Management
20%
Combination Antimicrobial Therapy
20%
Medicine and Dentistry
Early Intervention
100%
Cystic Fibrosis
100%
Side Effect
20%
Silo-Filler's Disease
20%
Health Care Cost
20%
Prevalence
20%
Drug Megadose
20%
Clinical Research
20%
Antibiotic Resistance
20%
Antimicrobial Therapy
20%
Management of Cystic Fibrosis
20%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
100%
Side Effect
16%
Prevalence
16%
Clinical Research
16%
Antimicrobial Resistance
16%
Lung Disease
16%
Antimicrobial Therapy
16%